• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

POLL: Are You Attending Revolutionizing Atopic Dermatitis (RAD)?

Article
Conference|Revolutionizing Atopic Dermatitis

Click here to answer this week's poll.

Are you attending Revolutionizing Atopic Dermatitis (RAD)?

Yes
No
f11photo/AdobeStock

f11photo/AdobeStock

If you can't attend RAD, click here to subscribe to our eNewsletters to receive daily conference updates live from Washington, DC.

Recent Videos
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
This series features 1 KOL.
This series features 1 KOL.
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
Elizabeth Kiracofe, MD, FAAD, and Jenny Murase, MD, experts on atopic dermatitis
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Video 5 - featuring 2 panelists in, "Quality of Life + Closing Thoughts
Related Content
Managing Food Allergies with Dupilumab in Pediatric Dermatology

Managing Food Allergies with Dupilumab in Pediatric Dermatology

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Hematologic Safety of Ruxolitinib Cream in Children with Atopic Dermatitis

Hematologic Safety of Ruxolitinib Cream in Children with Atopic Dermatitis

Article
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD

The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD

Podcast
Phase 3 Ruxolitinib Study Shows Higher Rates of Adolescent Repigmentation

Phase 3 Ruxolitinib Study Shows Higher Rates of Adolescent Repigmentation

Article
Clinical Insights Into Challenging Atopic Dermatitis Cases: Part 2

Clinical Insights Into Challenging Atopic Dermatitis Cases: Part 2

Article
© 2024 MJH Life Sciences

All rights reserved.